Andrew Wondra, MD
Interventional Pain Medicine · West Palm Beach, FLNPI 1194285692
Payments from drug & device makers
Across 113 payments — averaging $96.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Abbott$672
- Boston Scientific$667
- Globus Medical$412
- Biotronik NRO, Inc.$219
- SPR Therapeutics, Inc$136
- plus $504 from 11 others
What the payments were for
- Grants$5,00046%
- Travel & lodging$1,53514%
- Food & beverage$4,26939%
- Education$631%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 43 | $8,259 |
| Abbott | 15 | $672 |
| Boston Scientific | 15 | $667 |
| Globus Medical | 7 | $412 |
| Biotronik NRO, Inc. | 5 | $219 |
| SPR Therapeutics, Inc | 5 | $136 |
| Spinal Simplicity, LLC | 6 | $134 |
| Si-bone, Inc. | 3 | $76 |
| Curonix LLC | 3 | $63 |
| Stryker | 1 | $59 |
| Collegium Pharmaceutical, Inc. | 3 | $45 |
| Nevro Corp. | 2 | $35 |
| MML US, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $20 |
| Nalu Medical, Inc. | 1 | $19 |
| Forte Bio-pharma LLC | 1 | $15 |
| Bioventus LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$5,000
- INTELLIS ADAPTIVESTIM$1,562
- VANTA ADAPTIVESTIM$330
- ETERNA$184
- Intracept$144
- WaveWriter Alpha Prime 16$138
- Senza$135
- Prospera$121
How this compares
$10,868 in reported general payments places this provider in the 70th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 37 | $586 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $448 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $285 |
| Duloxetine Hcl | 17 | $266 |
| Tramadol Hcl | 14 | $77 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in West Palm Beach
- Ajay AntonyGainesville$1.9M
- Louis RasoJupiter$1.6M
- Gilbert MbeoOrlando$1.4M
- George BesongOrange City$1.2M
- Gary KaoMiddleburg$1.1M
- Neil EllisTampa$1.1M
- Alexis RentaBoynton Beach$1.1M
- Michael EspositoVero Beach$1M
- Jose RiveraTampa$993K
- Nomen AzeemRiverview$691K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.